Can I receive the COVID-19 vaccine if my liver function test results are elevated?

In real life, some individuals may exhibit elevated liver function test (LFT) results, prompting concerns about whether this affects their eligibility for COVID-19 vaccination. So, can individuals with elevated liver function indicators receive the COVID-19 vaccine?

Can individuals with elevated liver function indicators receive the COVID-19 vaccine?

Individuals with elevated liver function indicators should generally not receive the COVID-19 vaccine. Abnormal liver function—particularly elevated transaminase levels—may indicate active hepatitis, which can cause symptoms such as dull right upper quadrant abdominal pain, low-grade fever, nausea, vomiting, aversion to greasy foods, and even jaundice (yellowing of the skin and sclera). If these symptoms accompany abnormal LFTs, the underlying cause must be identified and appropriately treated. China has a high prevalence of hepatitis B virus (HBV) infection, and HBV is the leading cause of liver disease in the population.

Therefore, upon detecting abnormal liver function, initial evaluation should include testing for hepatitis viruses. If testing confirms HBV infection, oral antiviral therapy is required. If the abnormality stems from alcoholic liver disease or drug-induced liver injury, potentially hepatotoxic medications should be discontinued, alcohol consumption ceased, and active hepatoprotective treatment initiated.

If testing confirms HBV infection, antiviral therapy is indicated. Recommended first-line antiviral agents include entecavir and tenofovir, both of which effectively suppress HBV replication and slow progression of hepatic fibrosis. Additionally, nonalcoholic fatty liver disease (NAFLD) can also lead to abnormal LFTs. If NAFLD is suspected as the cause, lifestyle modifications—including a low-fat diet and regular physical activity—are essential to improve liver function. We hope this information is helpful to you.